Premium functions are now FREE OF CHARGE due to the modification of the investment data Data developments may cause some parts work incorrectly Incorrect sections - Financial statements, Earnings upcoming dates and calendars Please take our apologise. It will be fixed soon

STVN - Stevanato Group Spa


Close
21.88
0.300   1.371%

Share volume: 280,716
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$21.58
0.30
1.39%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
17.63%
1 Month
9.84%
3 Months
12.13%
6 Months
-29.03%
1 Year
-33.93%
2 Year
30.65%
Key data
Stock price
$21.88
P/E Ratio 
0.00
DAY RANGE
$21.48 - $22.62
EPS 
$0.00
52 WEEK RANGE
$16.56 - $35.46
52 WEEK CHANGE
-$0.34
MARKET CAP 
6.466 B
YIELD 
0.24%
SHARES OUTSTANDING 
295.540 M
DIVIDEND
$0.053
EX-DIVIDEND DATE
06/04/2024
NEXT EARNINGS DATE
11/05/2024
BETA 
0.67
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$492,315
AVERAGE 30 VOLUME 
$409,106
Company detail
CEO: Franco Moro
Region: US
Website: https://www.stevanatogroup.com/en/
Employees: 1,298
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

founded in 1949, stevanato group is committed to create systems, processes and services that guarantee the integrity of parenteral medicines. it is comprised of two operational divisions: - pharmaceutical systems (ompi and balda brands): specialized in ready-to-use glass containers and bulk primary packaging (syringes, cartridges, vials and ampoules); high quality and high precision plastic solutions for diagnostic, pharmaceutical and medical device applications. - engineering systems (spami, optrel, innoscan and svm brands): specialized in glass forming technology, inspection systems, assembly, packaging machines and serialization solutions for the pharmaceutical industry. these two divisions enjoy a close, synchronous relationship, featuring daily exchanges which ensure that stevanato group has complete control over the entire production process, from purchasing the finest raw materials to offering exceptional after-sales customer service. the group also benefits from the sglab activ

Recent news